title: Highlights of the 28(th) North American Cystic Fibrosis Conference 2014.
abstract: This is a selection of papers presented at the 28(th) North American Cystic Fibrosis Conference held in Atlanta in October 2014. The papers discussed are thought to be of particular interest to CF caregivers in the UK. Topics discussed include recent progress in the modification of the cystic fibrosis transmembrane regulator (CFTR), the potential of OligoG, a novel inhaled alginate mucolytic, and the changing approach to cystic fibrosis-related diabetes screening.
authors.affiliation: Consultant Respiratory Paediatrician, Royal London Hospital, Whitechapel Road, London, E1 1BB. Electronic address: chinedu.nwokoro@bartshealth.nhs.uk.
authors.forename: Chinedu E C
authors.initials: CE
authors.lastname: Nwokoro
mesh_terms: D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D007223:Infant; D016896:Treatment Outcome; D014481:United States
chemical_list: D019005:Cystic Fibrosis Transmembrane Conductance Regulator
keywords: Cystic Fibrosis; Cystic Fibrosis-related Diabetes; Mucolytic